$CNNE Cashflow Statement | Understand Stock

$CNNE

$16.32 +$0.03 (0.18%) Close

$CNNE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Equity in losses of unconsolidated affiliates
Ceridian
Dun & Bradstreet
Sightline
Other
Optimal Blue
Total equity in losses of unconsolidated affiliates

Distributions from investments in unconsolidated affiliates
Recognized losses and impairments of assets, net
Non-cash carried interest expense
Lease asset amortization
Stock-based compensation cost
Net loss from discontinued operations - see note Q
Changes in assets and liabilities, net of effects from acquisitions:
Other assets
Accounts payable, accrued liabilities, deferred revenue and other
Lease liabilities
Income taxes
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from sales of Dayforce shares
Proceeds from partial sale of D&B shares
Proceeds from partial sale of Alight shares
Proceeds from other sales of investments in unconsolidated affiliates, equity securities and other long- term investments
Proceeds from sales of VIBSQ, Legendary Baking and RCI
Proceeds from sale of AmeriLife
Proceeds from Optimal Blue Disposition, cash portion
Proceeds from sale of CorroHealth
Distributions from investments in unconsolidated affiliates
Dun & Bradstreet
Total distributions from investments in unconsolidated affiliates
Proceeds from the sale of property and equipment
Collections of notes receivable
Cash acquired upon acquisition of Legendary Baking and VIBSQ
Investment in System1
Investment in Paysafe, net of subscription fees earned
Investment in Alight, net of subscription fees earned
Investment in Sightline
Purchases of investments in unconsolidated affiliates
Additions to notes receivable
Purchase of other long-term investments
Additions to property and equipment and other intangible assets
Investments in Dun & Bradstreet, net of capitalized syndication fees
Investment in Optimal Blue
Cash deconsolidated at the inception of the Blue Ribbon Reorganization
Net other investing activities
Purchases of short-term investment securities
Proceeds from sale and maturity of short-term investment securities
Cash proceeds from the contribution of T-System to CorroHealth, net of cash transferred
Other acquisitions/disposals of businesses, net of cash acquired/disposed
Net cash provided by investing activities

Cash flows from financing activities:
Borrowings, net of debt issuance costs
Debt service payments
Equity offering proceeds, net of offering costs
Sale of noncontrolling interest in consolidated subsidiary
Subsidiary distributions paid to noncontrolling interest shareholders
Proceeds from Restaurant Group sale and leaseback of corporate office, net of issuance costs
Other activity in non-controlling interests
Payment for shares withheld for taxes and in treasury
Dividend paid
Purchases of treasury stock

Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at end of period, including cash of discontinued operations
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments